
mindsON RBQM | Episode 34: Change – Why 70% fail and how to succeed in Risk Management
Despite wide acknowledgment of the importance of Risk Management in clinical trials, implementation gaps persist. The draft ICH E6 (R3) guidelines place a strong emphasis on embedding risk-based thinking across all aspects of a trial from oversight to monitoring and data integrity. And yet, while 90% of organizations perform risk assessments, only 50% use Key Risk Indicators (KRIs) and just 25% implement Quality Tolerance Limits (QTLs) despite QTLs being a requirement since 2016.
So why are these essential elements still missing from many processes?
The truth is, change is hard. Studies show that up to 70% of change initiatives fail, often due to resistance, unclear communication, or cultural misalignment. But failure isn’t inevitable.
In This Episode:
Join our expert speakers, Keith Dorricott and Raik Knieknecht, as they share hard-won insights and field-tested strategies to help your organization not only comply with ICH E6 (R3) but thrive under it. This episode is highly interactive and grounded in real-world experience.
What You’ll Learn:
-
Why change initiatives fail and how to avoid the same pitfalls in your RBQM rollout
-
Common barriers in implementing KRIs, QTLs, and centralized monitoring
-
How to engage teams, clarify roles, and foster a culture of shared responsibility
-
Practical tools and frameworks to make Risk Management stick across your operations
-
Real-life stories of success (and failure) in adopting ICH E6 (R3)
Who Should Attend?
This session is ideal for:
-
Clinical Operations Leaders
-
Risk Managers
-
QA Professionals
-
Project Managers
-
Regulatory Affairs
-
Anyone involved in driving change and ensuring compliance with ICH E6 (R3)
Key Takeaways:
-
Understand the new Risk Management expectations of ICH E6 (R3)
-
Learn how to manage resistance to change and boost engagement
-
Get actionable frameworks to lead sustainable, cross-functional transformation
Don’t Miss This!
With Keith and Raik’s guidance, you’ll walk away with a deeper understanding of how to lead change, embed risk-based quality principles, and create lasting impact in your clinical trial operations.